Palatin Technologies, Inc. PTN

FY2026 · ended Jun 30, 2026 · Revenue $13.19M · Filed Sep 28, 2026

Palatin Technologies, Inc. (PTN) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $13.2 million and a net loss of $8.4 million. Free cash flow was -$13.6 million. As of Jun 30, 2026 it held $7.5 million in cash and investments and $223,679 in total debt.

Revenue
$13.19M
Net income
$-8.38M
+51.6% vs prior year
Operating cash flow
$-13.53M
+36.5% vs prior year
Free cash flow
$-13.58M
+36.2% vs prior year
EPS
$-2.96
+90.8% vs prior year
Dividend per share
None
Shares outstanding
1.78M
+83.0% vs prior year
Net cash
$7.27M
FY 2026
Operating margin
-65.7%
FY 2026

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTN (Nasdaq)
Fiscal year ends
June 30
Incorporated in
NJ
Headquarters
Cranbury, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
911216
Former names
INTERFILM INC (until Jun 14, 1996)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Jun 30, 2026
FY 2025
Jun 30, 2025
FY 2024
Jun 30, 2024
FY 2023
Jun 30, 2023
FY 2022
Jun 30, 2022
Revenue
$13.2M
$0
$4.5M
$4.9M
$1.5M
Operating income
-$8.7M
-$17.5M
-$22.5M
-$32.5M
-$36.6M
Net income
-$8.4M
-$17.3M
-$29.7M
-$24.0M
-$36.2M
Diluted EPS
-$2.96
-$32.15
—
—
—
Operating cash flow
-$13.5M
-$21.3M
-$31.5M
-$29.3M
-$29.9M
Free cash flow
-$13.6M
-$21.3M
-$31.5M
-$29.7M
-$30.2M
Total assets
$8.5M
$3.3M
$10.7M
$17.9M
$36.1M
Total liabilities
$1.8M
$8.0M
$10.9M
$19.7M
$19.8M
Stockholders' equity
$6.7M
-$4.8M
-$111,497
-$2.0M
$16.3M
Cash and investments
$7.5M
$2.6M
$9.5M
$14.0M
$29.9M
Total debt
$223,679
$163,781
$590,338
$1.1M
$506,656

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-K Annual report Sep 28, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Aug 3, 2026 Jul 28, 2026
8-K Current report
Listing notice, Regulation FD disclosure
May 18, 2026 May 18, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
8-K/A Amended current report
Shareholder vote results
Dec 19, 2025 Jul 25, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.